Food and Drug Administration’s Role in Dermatology, An Issue of Dermatologic Clinics
- 1 Edición, Volumen 40-3 - 24 de junio de 2022
- Última edición
- Editor: Markham C. Luke
- Idioma: Inglés
In this issue, guest editors bring their considerable expertise to this important… Leer más
Descripción
Descripción
In this issue, guest editors bring their considerable expertise to this important topic.
Puntos claves
Puntos claves
Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
Índice
Índice
The History of Dermatology and Dermatologists at the US Food and Drug Administration
The Food and Drug Administration’s Role in Dermatologic Drug Development
Postmarket Assessment for Drugs and Biologics Used in Dermatology and Cutaneous Adverse Drug Reactions
How Does the Food and Drug Administration Approve Topical Generic Drugs Applied to the Skin?
Dermatology Drugs for Children—U.S. Food and Drug Administration Perspective
Regulation of Medical Devices for Dermatology
Regulation of Cosmetics in the United States
Cutaneous Pharmacokinetic Approaches to Compare Bioavailability and/or Bioequivalence for Topical Drug Products
Measuring What Matters to Patients in Dermatology Drug Development: A Regulatory Perspective
The Food and Drug Administration’s Role in Dermatologic Drug Development
Postmarket Assessment for Drugs and Biologics Used in Dermatology and Cutaneous Adverse Drug Reactions
How Does the Food and Drug Administration Approve Topical Generic Drugs Applied to the Skin?
Dermatology Drugs for Children—U.S. Food and Drug Administration Perspective
Regulation of Medical Devices for Dermatology
Regulation of Cosmetics in the United States
Cutaneous Pharmacokinetic Approaches to Compare Bioavailability and/or Bioequivalence for Topical Drug Products
Measuring What Matters to Patients in Dermatology Drug Development: A Regulatory Perspective
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Volumen: 40-3
- Publicado: 27 de junio de 2022
- Idioma: Inglés
Sobre el editor
Sobre el editor
ML
Markham C. Luke
Afiliaciones y experiencia
Food and Drug Administration